B cell subsets in different lymphatic tissues, blood and peritoneal cells of wild-type and SPPL2a-deficient mice
| Cell type | SPPL2a+/+ | SPPL2a−/− | P-value | |||
| Mean | SD | Mean | SD | |||
| BM (% of viable cells) | ||||||
| B cells | B220+ | 21.4 | 6.1 | 15.3 | 2.5 | 0.031* |
| Pro– /pre–B cells | B220+ IgM− | 8.5 | 1.9 | 10.3 | 2 | 0.099 |
| Immature B cells | B220+ IgM+ | 3.6 | 1.9 | 4.1 | 2.3 | 0.694 |
| Recirculating B cells | B220high | 8.6 | 3.6 | 0.7 | 0.2 | <0.001*** |
| Spleen (% of viable cells) | ||||||
| B cells | B220+ | 45.6 | 6.6 | 23.9 | 13.1 | <0.001*** |
| T1 transitional | B220+ CD21low CD24high | 7.5 | 0.7 | 8.2 | 4.9 | 0.785 |
| T2 transitional | B220+ CD21high CD24high | 11.2 | 3.1 | 0.5 | 0.6 | <0.001*** |
| Mature B cells | B220+ CD21low CD24low | 23.9 | 7.1 | 7.0 | 4.4 | 0.007** |
| Spleen (×106 splenocytes) | ||||||
| B cells | B220+ | 33.3 | 13.5 | 4.2 | 2.2 | 0.021* |
| T1 transitional | B220+ CD21low CD24high | 5.2 | 2.3 | 1.8 | 0.6 | 0.056 |
| T2 transitional | B220+ CD21high CD24high | 7.9 | 2.9 | 0.1 | 0.1 | 0.013* |
| Mature B cells | B220+ CD21low CD24low | 17.8 | 7.3 | 1.8 | 1.2 | 0.021* |
| Peritoneal cells (% of viable cells) | ||||||
| B cells | B220+ CD19+ | 49.2 | 10.8 | 11.4 | 5.0 | <0.001*** |
| B1 | B220neg/low CD19high | 34.2 | 13.8 | 6.7 | 4.7 | <0.001*** |
| B2 | B220high CD19+/low | 15.1 | 6.9 | 2.1 | 1.7 | 0.001** |
| Cell type | SPPL2a+/+ | SPPL2a−/− | P-value | |||
| Mean | SD | Mean | SD | |||
| BM (% of viable cells) | ||||||
| B cells | B220+ | 21.4 | 6.1 | 15.3 | 2.5 | 0.031* |
| Pro– /pre–B cells | B220+ IgM− | 8.5 | 1.9 | 10.3 | 2 | 0.099 |
| Immature B cells | B220+ IgM+ | 3.6 | 1.9 | 4.1 | 2.3 | 0.694 |
| Recirculating B cells | B220high | 8.6 | 3.6 | 0.7 | 0.2 | <0.001*** |
| Spleen (% of viable cells) | ||||||
| B cells | B220+ | 45.6 | 6.6 | 23.9 | 13.1 | <0.001*** |
| T1 transitional | B220+ CD21low CD24high | 7.5 | 0.7 | 8.2 | 4.9 | 0.785 |
| T2 transitional | B220+ CD21high CD24high | 11.2 | 3.1 | 0.5 | 0.6 | <0.001*** |
| Mature B cells | B220+ CD21low CD24low | 23.9 | 7.1 | 7.0 | 4.4 | 0.007** |
| Spleen (×106 splenocytes) | ||||||
| B cells | B220+ | 33.3 | 13.5 | 4.2 | 2.2 | 0.021* |
| T1 transitional | B220+ CD21low CD24high | 5.2 | 2.3 | 1.8 | 0.6 | 0.056 |
| T2 transitional | B220+ CD21high CD24high | 7.9 | 2.9 | 0.1 | 0.1 | 0.013* |
| Mature B cells | B220+ CD21low CD24low | 17.8 | 7.3 | 1.8 | 1.2 | 0.021* |
| Peritoneal cells (% of viable cells) | ||||||
| B cells | B220+ CD19+ | 49.2 | 10.8 | 11.4 | 5.0 | <0.001*** |
| B1 | B220neg/low CD19high | 34.2 | 13.8 | 6.7 | 4.7 | <0.001*** |
| B2 | B220high CD19+/low | 15.1 | 6.9 | 2.1 | 1.7 | 0.001** |
Cells of each genotype were analyzed by flow cytometry to determine the indicated cell populations as percentage of viable cells (PI−) or absolute cell numbers, respectively. BM, n = 7; spleen, n = 9; blood, n = 6; LNs n = 5; peritoneal cells, n = 12. Results are shown as mean ± SD. ***, P < 0.01; **, P < 0.01; *, P < 0.05, unpaired Student’s t test.